Pharmaceutical Microbiology UK Virtual Conference

Exploring Agile Contamination Control Strategy

, Online Event , Your Computer

Pharmaceutical Microbiology as an industry is projected to see significant advancements in the next five years. This forecast is largely attributed to rapid microbiology testing, which has accounted for $3.5 billion last year, while projected to reach nearly double at $6 billion by 2025, and an estimated CAGR of 8.3% leading up to 2025.

At the very core of pharmaceutical microbiology is the accurate and reliable detection of microorganisms that would otherwise contaminate the pharmaceutical products manufactured. This demand for more rapid methods for detection and identification will be addressed alongside equally important areas such as: contamination control strategies and environmental monitoring, process automation, and discussing effective strategies to meet updated regulatory requirements.

Join us at our 10th Annual Pharmaceutical Microbiology Virtual Conference to explore the newest case studies and latest technologies that tackle the most pressing challenges and are pushing innovation in world of pharmaceutical microbiology.

Benefits of Attending

  • INSIGHT into the complex regulatory landscape and extensive regulator expectations
  • EXPLORE the latest advancements in environmental monitoring technology and strategy
  • DELVE into contemporary case studies delivered by experts in agile contamination control
  • ATTAIN expert tuition in environmental monitoring and aseptic-containment strategies for
  • hazardous products at the post-conference workshops
  • DISCUSS robust strategies in global pharmaceutical distribution during the COVID-19 pandemic

Who should attend

  • Heads of Aseptic Processing
  • Heads of Microbiology
  • Global Quality Directors
  • Heads of GMP Compliance
  • Quality & Compliance Heads
  • Microbiology Senior Specialists
  • Heads of Site Compliance
  • Heads of Sterile Technology
  • Global Microbiology Analytical Experts
  • Directors of Quality Control Biology

Featured Speakers

  • BenoĆ®t Ramond, Head of Microbiology & Sterile Technology, Sanofi
  • Cheryl Dennis, Principal Quality Control Scientist CAR T, Bristol Myers Squibb
  • Di Morris, Senior Manager, Team Leader, GSK
  • Francesca Burberi, CCI Projects Sr. Consultant, Eli Lilly Italia SpA
  • Fred Ohsiek, Senior Specialist, Cleaning Validation, Novo Nordisk
  • Helen Gates, Global Technical Consultant, Ecolab
  • Henrietta Vinneras, Senior Manager, Microbiology & Aseptic Technique, Fresenius Kabi
  • Ian Ramsay, Independent Quality Consultant, RamsayPharma
  • James Drinkwater, PHSS Head of Aseptic Processing and Containment Special Interest Group & F Ziel GmbH Head of GMP Compliance, PHSS: Pharmaceutical & Healthcare Sciences Society
  • Jim Polarine Jr, Senior Global Technical Service Manager, Steris Corporation
  • Johannes Oberdoerfer, Lead Scientist, Rapid Microbiology Methods, Boehringer Ingelheim Pharma GmbH & Co. KG
  • Joseph McCall, Associate Director, QA Technical Service , ADMA Biologics
  • Juliana Nassette, Team Lead QC Microbiology, Kite Pharma
  • Maximilian Augustin, Validation Manager, Roche Diagnostics Gmbh
  • Philippe Dhoms, Head of Bioprocess Development and Industrialisation, Boehringer-Ingelheim
  • Tony Cundell, Principal Consultant, Microbiological Consulting, LLC

Please fill in your name and email to receive the Virtual Conference Agenda of this event.


The venue is not yet available for this event.
Follow this event to be informed when the venue is available and stay informed on other changes.

Event details
Organizer : SMi
Event type : Conference
Reference : ASDE-22521